Transforming the Study and Practice of Cancer Medicine
As a research-based institution, Stony Brook University Cancer Center is dedicated to understanding the biology and mechanisms of cancer. The goal is to create more effective and targeted treatments, as well as prevent specific cancers.
The entire spectrum of cancer research at the Cancer Center is broadening under the progressive leadership of Yusuf A. Hannun, MD, Director, Stony Brook Cancer Center, and Patricia A. Thompson-Carino, PhD, Deputy Director for Research, Stony Brook Cancer Center. Explorations extend from basic investigation to work that translates directly into the development of new medicines.
Three thematic programs are driving this cutting-edge research: Cancer Lipids and Metabolism, Oncogenic Drivers and Mechanisms of Carcinogenesis, and Computer and Engineering Sciences in Oncology. These are areas that have been identified as having high levels of scientific excellence and opportunities for interaction and collaboration among scientists. They also build on areas of exceptional strength at Stony Brook University, including applied math, engineering sciences, computational biology, imaging, metabolism, chemistry, and computer sciences.
- Cancer Lipids and Metabolism
Leaders: Lina Obeid, MD; Geoffrey Girnun, PhD
- Oncogenic Drivers and Mechanisms of Carcinogenesis
Leaders: Scott Powers, PhD; Ute Moll, MD
- Imaging, Bioinformatics and Engineering Sciences
Leaders: Joel Saltz, MD, PhD; Patricia Thompson-Carino, PhD
A Transformative Milestone
As the premier academic medical center on Long Island, Stony Brook is committed to acquiring and employing advanced technology that can propel research excellence. Among the latest acquisitions are a cyclotron and a PET scanner. The cyclotron was purchased with a donation from Kavita and Lalit Bahl, who have also generously provided funds for the creation of the Kavita and Lalit Bahl Center for Metabolomics and Imaging.
A World-Class Cancer Center
Ambitious ideas, imaginative solutions and exceptional leadership are the cornerstone of a top facility. Stony Brook Cancer Center is continuing to focus on developing programs that will foster breakthroughs in the study and practice of cancer medicine.
With the clinical, research and educational components already in place, Stony Brook Cancer Center is positioned to be named a National Cancer Institute (NCI)-designated cancer center within the next five years. NCI-designated cancer centers are recognized for their scientific leadership, resources, and the depth and breadth of their research in basic, clinical, and population science and for outstanding delivery of comprehensive cancer care.
The Future: The MART
In addition, the state-of-the-art Medical and Research Translation (MART) building will open in early 2019. As part of its core mission, the MART is devoted to cancer research and care, including the new location for the outpatient services for adults and children with cancer. The MART will also house advanced biomedical imaging and biomedical informatics, including a PET scanner. The Kavita and Lalit Bahl Center for Metabolomics and Imaging will be permanently located on Level 9 in the MART.